HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Xiao Selected Research

Monoclonal Antibodies

4/2022Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.
5/2014RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Xiao Research Topics

Disease

66Neoplasms (Cancer)
04/2024 - 10/2008
14Carcinogenesis
01/2023 - 10/2011
10Breast Neoplasms (Breast Cancer)
01/2022 - 01/2014
8Inflammation (Inflammations)
02/2023 - 01/2013
6Deafness (Deaf Mutism)
03/2024 - 08/2016
6Nasopharyngeal Carcinoma
01/2024 - 01/2019
6Fibrosis (Cirrhosis)
06/2023 - 10/2006
6Lung Neoplasms (Lung Cancer)
05/2023 - 06/2003
6Glioblastoma (Glioblastoma Multiforme)
12/2019 - 07/2013
5Pain (Aches)
10/2023 - 01/2016
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2023 - 09/2020
5Neoplasm Metastasis (Metastasis)
05/2023 - 02/2015
5Hearing Loss (Hearing Impairment)
01/2022 - 01/2016
4Wounds and Injuries (Trauma)
09/2022 - 10/2016
3Adenocarcinoma
04/2024 - 04/2011
3Myocardial Infarction
04/2024 - 05/2015
3Infections
12/2023 - 12/2017
3Autoimmune Diseases (Autoimmune Disease)
09/2023 - 05/2021
3Lupus Nephritis
09/2023 - 09/2020
3Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 01/2013
3Neuroinflammatory Diseases
02/2022 - 07/2020
3Ischemic Stroke
01/2022 - 02/2019
3Stroke (Strokes)
01/2022 - 10/2015
3Melanoma (Melanoma, Malignant)
01/2022 - 01/2021
3Triple Negative Breast Neoplasms
01/2022 - 12/2017
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2018
3Malignant Mesothelioma
11/2021 - 01/2017
3Carcinoma (Carcinomatosis)
01/2020 - 11/2016
3Adenocarcinoma of Lung
09/2019 - 04/2011
3Prostatic Neoplasms (Prostate Cancer)
05/2018 - 10/2011
3Heart Failure
01/2018 - 11/2012
3Leukemia
01/2017 - 04/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2011 - 10/2008
2Cardiovascular Diseases (Cardiovascular Disease)
02/2023 - 02/2019
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2022 - 01/2021
2Multiple Sclerosis
02/2022 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 01/2013
2Mesothelioma
11/2021 - 01/2017
2Neuralgia (Stump Neuralgia)
11/2021 - 10/2021
2Renal Cell Carcinoma (Grawitz Tumor)
04/2021 - 12/2017
2Necrosis
01/2021 - 06/2014
2Ischemia
07/2020 - 12/2013
2Retinal Perforations
04/2020 - 01/2018
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 01/2019
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2012
2Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 01/2016
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020 - 07/2015

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
16Proteins (Proteins, Gene)FDA Link
08/2023 - 04/2011
16MicroRNAs (MicroRNA)IBA
01/2021 - 10/2011
16Long Noncoding RNAIBA
01/2020 - 01/2015
9RNA (Ribonucleic Acid)IBA
01/2022 - 08/2014
7Messenger RNA (mRNA)IBA
11/2019 - 10/2011
6Transfer RNA (tRNA)IBA
01/2022 - 01/2016
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2002
5Therapeutic UsesIBA
02/2024 - 07/2015
5AntibodiesIBA
09/2023 - 05/2014
5Phosphotransferases (Kinase)IBA
01/2022 - 01/2010
5Mitochondrial DNA (mtDNA)IBA
01/2022 - 08/2016
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2013
5Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 10/2008
4Immunoglobulin G (IgG)IBA
09/2023 - 09/2020
4CytokinesIBA
06/2023 - 11/2012
4AsbestosIBA
01/2022 - 06/2012
4Competitive Endogenous RNAIBA
09/2020 - 11/2016
3CateninsIBA
04/2024 - 01/2020
3Interleukin-6 (Interleukin 6)IBA
12/2022 - 07/2015
3Immune Checkpoint InhibitorsIBA
01/2022 - 04/2021
3Interleukin-10 (Interleukin 10)IBA
01/2022 - 07/2020
3PlatinumIBA
01/2021 - 01/2019
3Transforming Growth Factor beta (TGF-beta)IBA
01/2019 - 01/2009
3ErbB Receptors (EGF Receptor)IBA
01/2014 - 10/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 02/2010
2Antinuclear AntibodiesIBA
08/2022 - 09/2020
2Monoclonal AntibodiesIBA
04/2022 - 05/2014
2CuprizoneIBA
02/2022 - 01/2022
2LigandsIBA
01/2022 - 12/2011
2GemcitabineFDA Link
01/2022 - 01/2019
2Propofol (Diprivan)FDA LinkGeneric
01/2022 - 01/2022
2montelukast (Singulair)FDA Link
01/2022 - 01/2021
2Serpentine Asbestos (Chrysotile)IBA
01/2022 - 11/2021
2FSC 231IBA
11/2021 - 10/2021
2Substance PIBA
11/2021 - 10/2021
2Circular RNAIBA
01/2021 - 02/2019
2Small Cytoplasmic RNAIBA
01/2021 - 01/2019
2Retinaldehyde (Retinal)IBA
04/2020 - 09/2015
2ChromatinIBA
01/2020 - 04/2002
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 09/2019

Therapy/Procedure

30Therapeutics
04/2024 - 01/2010
9Drug Therapy (Chemotherapy)
01/2023 - 09/2014
7Immunotherapy
01/2023 - 12/2018
4Vitrectomy
01/2022 - 01/2018
3Chemoradiotherapy
02/2024 - 01/2019
3Radiotherapy
06/2023 - 01/2021
2Cochlear Implantation
03/2024 - 01/2020
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2024 - 01/2019
2Precision Medicine
02/2023 - 11/2019
2Induction Chemotherapy
01/2022 - 01/2019
2Sutures (Suture)
01/2020 - 01/2018